Will I put the weight back on?

Up to 95% of weight-loss may be sustained 12 months after the Balloon exits the body! ¹

How is the Balloon placed?

The placement takes place during a 15-minute outpatient visit. Allurion is the first gastric balloon that requires no endoscopy* or anaesthesia for placement or removal. Simply swallow a capsule containing the deflated Balloon with a catheter: once the Balloon is confirmed to be in your stomach via x-ray, the Balloon is filled with water through the catheter. A second x-ray takes place to ensure the Balloon is filled correctly.

Does a doctor need to remove the Balloon?

No. After approximately 16 weeks, the Balloon deflates and passes naturally. In very rare cases, an intervention might be required.*

How much weight can be lost with Allurion? After approximately 16 weeks of the Allurion Programme, multiple clinical studies have demonstrated that patients lose on average 10–15% of their total body weight. If you still want to lose more weight, a second Balloon can be placed after completing the first programme.

After approximately 16 weeks of the Allurion Programme, multiple clinical studies have demonstrated that patients lose on average 10–15% of their total body weight. If you still want to lose more weight, a second Balloon can be placed after completing the first programme.

Is the Allurion Program more effective than dieting alone?

Yes! The Allurion Program, a combination of our unique swallowable gastric balloon and a supported lifestyle change program, leads to nearly 2.5 times the weight loss than a lifestyle change program alone, according to an independent study.(superscript 1) In another study, three-quarters of participants who attempted to lose weight over a year through calorie-controlled or restricted diets (72% of participants), exercise programs or courses (22%), and pharmaceutical treatments (12%), did not achieve a clinically meaningful weight loss defined as at least 5% of their body weight.(superscript 2) The evidence shows that these isolated methods alone are not enough. The 6-month Allurion Program combines medical support and a weight-loss device (Allurion Gastric Balloon), digital tools (Allurion Connected Scale, Allurion Health Tracker and Allurion App) and nutritional coaching to kick-start your weight loss and help you form lifelong healthy habits to maintain the weight loss. Read more here References Results at 16 weeks. Raftopoulos, I et al Holyoke Medical Center. Holyoke, MA An Intensive 52 Week Nutritional, Exercise and Behavior Modification Program: Comparing With or Without the Allurion IGB Presented at ASMBS 2019 Three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful (ampproject.org) In another study, three-quarters of participants who attempted to lose weight over a year through calorie-controlled or restricted diets (72% of participants), exercise programs or courses (22%), and pharmaceutical treatments (12%), did not achieve a clinically meaningful weight loss defined as at least 5% of their body weight.² The evidence shows that these isolated methods alone are not enough. The 6-month Allurion Program combines medical support and a weight-loss device (Allurion Gastric Balloon), digital tools (Allurion Connected Scale, Allurion Health Tracker and Allurion App) and nutritional coaching to kick-start your weight loss and help you form lifelong healthy habits to maintain the weight loss.¹ ² **

What are the differences between the Allurion Balloon and other gastric balloons?

The Allurion Balloon is the world’s first and only gastric balloon without the need for surgery, endoscopy* or anaesthesia for balloon placement and removal. The balloon is swallowed as a capsule during a 15-minute placement which means less downtime or time off work for our patients. Designed to pass naturally at approximately 16 weeks, the Allurion Balloon maximizes weight loss while minimizing time spent in the body, making it a more effective option than longer 6-month endoscopic balloons, where 80% of weight loss is achieved within the first 3 months.1 The Allurion Balloon is a safer option, with fewer side effects. It has a significantly lower intolerance rate compared to 12-month endoscopic balloons (1-3% vs 14.4%)2,3, with an overall serious adverse event rate that is 10 times lower than other liquid-filled balloons.4-10 Made from vegan polyurethane, a material that’s much thinner and more flexible than the silicone material in endoscopic balloons, the Allurion Balloon flexes and adapts as your stomach moves, ensuring a snug and comfortable fit.

Choose your country or region in order to display more relevant content.

Select

Other country or region

Country

Language

Continue

Allurion Gastric Balloon

Lose an average 10-15% of your total body weight in approximately 16 weeks with the Allurion Program*.

Allurion Patients

Lbs lost

Countries

The Allurion Balloon is not currently approved in the USA. If interested in the AUDACITY study being conducted in the USA, please click below.

Learn More

Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination with Compute Health Acquisition Corp.

Read the Press Release

Stay up to date with the latest news from Allurion, including press releases, media coverage, and multimedia content.

Enter

* Ienca et al. Obes Surg. 2020 2. Vantanasiri et al. Obes Surg 2020.
** Ienca, Presented at TOS Obesity Week, 2020.
*** In rare cases, the Allurion Balloon may require endoscopic or surgical intervention for removal.
**** The Allurion Balloon must be used in conjunction with a supervised nutrition and behavior modification program. Allurion advises a 6-month follow-up. Its duration is defined by the physician and may vary depending on the physician and patient profile.

Quote from Lucy Jones, dietician http://www.lucyjonesdietitian.co.uk
Clinical Trial Reports: DAA069 and DAA105
Jamal et al. Obes Surg. 2019 Apr;29(4):1236-1241.
Raftopoulos and Giannakou. SOARD. 2017 Jul;13(7):1174-1182.
Al Sabah, S., et al. SOARD. 2018, 14(3), 311-317.
Machytka E et al. Endoscopy. 2017 Feb;49(2):154-160.
Genco et al. Obes Surg 2017,DOI 10.1007/s11695-017-2877-1
Al-Subaie S et al. Int J Surg. 2017 Dec;48:16-22.
Ienca et al. Submitted to SOARD. Abstract A278, presented at Obesity Week, 2018, Nashville, USA
Genco et al. Abstract A185. Oral Presentation at Obesity Week, 2018, Nashville, USA
Ienca et al. Abstract 237, presented at IFSO 2019, Madrid, Spain
Raftopoulos et al. Abstract 1978. Presented at ACS 2019, San Francisco, United States
Ienca et al. Presented at TOS 2020
Please read the Elipse balloon IFU for further information: https://www.eifu.online/LAB/02
Ienca et al. Accepted abstract at Obesity Week 2020

Chat with Ally